Haloperidol Decanoate
NDC Package 55390-413-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Haloperidol Decanoate is used for long-term treatment of a certain mental/mood disorder (schizophrenia). Marketed by Bedford Laboratories, this product is identified by NDC 55390-413 and is authorized under FDA application ANDA075305.

Identification & Billing

NDC Package Code
55390-413-01
Package Description
10 VIAL in 1 BOX / 1 mL in 1 VIAL
Product Code
55390-413
11-Digit Billing Format
55390041301

Clinical Specifications

Proprietary Name
Haloperidol Decanoate
Dosage Form
-
Usage Information
Haloperidol decanoate is used for long-term treatment of a certain mental/mood disorder (schizophrenia). It may be used in people who have trouble remembering to take medication every day. This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can also prevent suicide in people who are likely to harm themselves. It also reduces aggression and the desire to hurt others. It can decrease negative thoughts and hallucinations. Haloperidol decanoate is a long-acting form of psychiatric medication (antipsychotic-type) that works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain.

Regulatory & Marketing

Labeler Name
Bedford Laboratories
FDA Application #
ANDA075305
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-01-1998
End Marketing Date
05-31-2011
Listing Expiration
05-31-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (55390-413). Click a package code to view its specific billing and regulatory data.

55390-413-05
1 VIAL in 1 BOX, UNIT-DOSE / 5 mL in 1 VIAL

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55390-413-01 identifies a specific commercial package of 10 vial in 1 box / 1 ml in 1 vial of Haloperidol Decanoate, labeled by Bedford Laboratories. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bedford Laboratories on October 01, 1998. The current certification is valid through May 31, 2011.

What are the primary indications for this medication?

Haloperidol decanoate is used for long-term treatment of a certain mental/mood disorder (schizophrenia). It may be used in people who have trouble remembering to take medication every day. This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can also prevent suicide in people who are likely to harm themselves. It also reduces aggression and the desire to hurt others. It can decrease negative thoughts and hallucinations. Haloperidol decanoate is a long-acting form of psychiatric medication (antipsychotic-type) that works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain.

How is this Bedford Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55390041301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55390-413-01
11-Digit CMS (5-4-2)
55390-0413-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.